TriSalus Life Sciences (TLSI) Debt Ratio (2023 - 2026)

TriSalus Life Sciences' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.47 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 57.92% year-over-year to 0.47 in Q1 2026; TTM through Mar 2026 was 0.47, a 57.92% decrease from a year earlier, with the FY2025 full-year figure at 0.94, up 1.52% from the prior year.
• Debt Ratio eased to 0.47 in Q1 2026 per TLSI's latest filing, from 0.94 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.11 in Q1 2025 and bottomed at 0.05 in Q2 2023.
• The 4-year median for Debt Ratio is 0.79 (2024), against an average of 0.73.
• Across the five-year window, Debt Ratio jumped 1176.54% in 2024 and slumped 57.92% in 2026, its largest moves.
• Year by year, Debt Ratio stood at 0.05 in 2023, then surged by 1691.81% to 0.92 in 2024, then climbed by 1.52% to 0.94 in 2025, then plunged by 50.17% to 0.47 in 2026.
• Per Business Quant, the three latest TLSI Debt Ratio figures stand at 0.47 (Q1 2026), 0.94 (Q4 2025), and 0.9 (Q3 2025).